Christensen King & Associates Investment Services’s AbbVie ABBV Stock Holding History

Christensen King & Associates Investment Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$522K	Hold	2,075	–	–	0.21%	59
2026 Q1	$451K	Buy	2,075 +1	+0%	+$222	0.19%	65
2025 Q4	$474K	Sell	2,074 -199	-9%	-$45.3K	0.2%	61
2025 Q3	$526K	Buy	2,273 +401	+21%	+$81.7K	0.23%	56
2025 Q2	$347K	Buy	1,872 +216	+13%	+$40.1K	0.16%	73
2025 Q1	$333K	Buy	1,656 +1	+0.1%	+$194	0.16%	73
2024 Q4	$298K	Buy	1,655 +1	+0.1%	+$184	0.14%	77
2024 Q3	$327K	Buy	1,654 +1	+0.1%	+$187	0.15%	74
2024 Q2	$283K	Buy	1,653 +2	+0.1%	+$331	0.14%	76
2024 Q1	$301K	Buy	1,651 +15	+0.9%	+$2.58K	0.15%	78
2023 Q4	$254K	Buy	+1,636	New	+$239K	0.14%	84

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Christensen King & Associates Investment Services's ABBV Position: Q2 2026 in Review

Christensen King & Associates Investment Services held its AbbVie (ABBV) position steady in Q2 2026 at 2,075 shares worth $522K. The position accounts for 0.21% of the portfolio, ranked #59.

Christensen King & Associates Investment Services first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $526K in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Christensen King & Associates Investment Services held 2,075 shares of AbbVie worth $522K as of Q2 2026.
Christensen King & Associates Investment Services left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.21% of Christensen King & Associates Investment Services's portfolio in Q2 2026, its #59 holding.
Christensen King & Associates Investment Services first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Christensen King & Associates Investment Services's AbbVie position peaked at $526K in Q3 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Christensen King & Associates Investment Services's 13F filing for Q2 2026, filed 14 Jul 2026.